Results 171 to 180 of about 174,772 (308)
NEW IMMUNOSUPPRESSIVE AGENTS: A WAY TO GET RID OF CORTICOSTEROIDS?
Emmanuel Morélon, Henri Kreis
openalex +1 more source
Tan et al. developed a platelet membrane‐coated, thermoresponsive liposome for targeted, light‐controlled delivery of fluorinated peptides that promotes programmed death‐ligand 1 degradation, induces tumor immunogenic cell death, suppresses solid tumors and metastases, and triggers durable immune memory, offering a promising strategy for peptide‐based ...
Manman Tan +19 more
wiley +1 more source
Cancer incidence and the influence of immunosuppressive agents in Korean patients with systemic lupus erythematosus: a retrospective cohort study. [PDF]
Cho SK +6 more
europepmc +1 more source
Vaccines: Considerations for pediatric dermatology patients on immunosuppressive agents. [PDF]
Munshi MA +3 more
europepmc +1 more source
Safety of tacrolimus, an immunosuppressive agent, in the treatment of rheumatoid arthritis in elderly patients [PDF]
Shinichi Kawai, Kazuhiko Yamamoto
openalex +1 more source
Spatial transcriptomic analysis of Anaplastic thyroid carcinoma (ATC)‐differentiated thyroid carcinoma (DTC) coexisting tumors reveals that coexisting DTC regions with ATC‐like genomic alterations undergo sequential transcriptomic reprogramming and immune microenvironment remodeling, ultimately evolving into a full ATC pathological phenotype.
Kang Ning +19 more
wiley +1 more source
Efficacy and safety of 12 immunosuppressive agents for idiopathic membranous nephropathy in adults: A pairwise and network meta-analysis. [PDF]
Liu J, Li X, Huang T, Xu G.
europepmc +1 more source
This article examines the central role of RIPK1 in the pathogenesis of sepsis‐induced lung injury. It elucidates how RIPK1 initiates an inflammatory cascade by activating JAK1‐STAT3 signaling, leading to CXCL1‐mediated neutrophil infiltration. Importantly, it demonstrates that pharmacological inhibition of RIPK1 effectively attenuates inflammation and ...
Hao Sun +15 more
wiley +1 more source

